GYENNO Redefines Health Tech with Spoon II and Gait Aid at CES 2018

GYENNO redefines health tech with Smart tools empowering millions of people who are living with Parkinson’s Disease and similar conditions. GYENNO is showcasing its latest GYENNO Spoon II and Gait Aid at CES 2018.

Living with the tremors and symptoms of Parkinson’s Disease and other neurodegenerative conditions is challenging, taking extra effort to do ordinary tasks. One company has created medical grade equipment based on robotic technology, IoT and artificial intelligence to help the millions of people suffering from dyskinesia (type of movement disorders characterized by involuntary muscle movements) to live more comfortably and improve their overall quality of life.

GYENNO is introducing their newest utensil, the GYENNO Spoon II, which helps patients avoid the embarrassment of not being able to feed themselves. The intelligent stabilization utensil counteracts tremors as food is picked up and carried to the mouth.

Based on rehabilitation robotics technology, the new and improved spoon is now smaller and smarter than earlier versions of the spoon. It works to smooth movements if hands start to shake and has a deep bowl designed so people can eat soup without spilling.

Other new features include:

  • A fork option which uses the rotating shaft that allows patients to twirl spaghetti
  • Improved anti-tremor capability for both vertical and horizontal shaking
  • Works with either hand and shaking control varies depending on whether a user wants to scoop up food or put it in the mouth
  • No charging station and a battery built inside the device for easier on-the-go functionality
  • Uses WiFi and has a built-in sensor to track motion and collect data for researchers and doctors better understand the disease

The GYENNO Gait Aid Equipment also on display at CES will help the 60 percent of later-stage Parkinson’s patients who experience ‘gait freeze’, or the inability to move, and thus are at risk for falls. Gait disorder is caused by a deficiency of dopamine in the basal ganglia circuit in the brain, leading to motor defects. Gait is one of the most affected motor characteristics of this disorder.

GYENNO’s Gait Aid uses smart sensors to detect when a person might experience this problem and provides audio, visual, or tactical alerts so a patient can avoid a fall. The solution includes automatic detection of the problem and several types of patient alerts as well as gait data collection and the development of an adaptive algorithm based on deep learning. This all improves the accurate identification of each user’s gait issue.

Visit GYENNO, and see their solutions in action, at CES 2018 at LVCC South Hall 2, Sands Level 2, booth # 43158.